UK markets open in 6 hours 3 minutes

ORIC Pharmaceuticals, Inc. (ORIC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.83+0.60 (+7.29%)
At close: 04:00PM EDT
9.05 +0.22 (+2.49%)
After hours: 05:13PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
62,130
85,172
61,680
56,858
35,921
Selling general and administrative
25,323
25,608
25,087
22,013
13,422
Total operating expenses
87,453
110,780
86,767
78,871
49,343
Operating income or loss
-87,453
-110,780
-86,767
-78,871
-49,343
Total other income/expenses net
-5,000
10,083
-2,355
15
-24,666
Income before tax
-91,046
-100,697
-89,122
-78,715
-73,703
Income from continuing operations
-91,046
-100,697
-89,122
-78,715
-73,703
Net income
-91,046
-100,697
-89,122
-78,715
-73,703
Net income available to common shareholders
-91,046
-100,697
-89,122
-78,715
-73,703
Basic EPS
-1.98
-1.96
-2.25
-2.07
-3.36
Diluted EPS
-1.98
-1.96
-2.25
-2.07
-3.36
Basic average shares
47,101
51,451
39,655
37,954
21,942
Diluted average shares
47,101
51,451
39,655
37,954
21,942